20-Mar-2026
No headlines found.
No press releases found.
No news found.
ProShares Ultra Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the daily performance of the NASDAQ Biotechnology Index.
ProShares Ultra Nasdaq Biotechnology trades on the NASDAQ stock market under the symbol BIB.
As of March 20, 2026, BIB stock price declined to $75.08 with 14,373 million shares trading.
BIB has a market cap of $75.83 million. This is considered a Micro Cap stock.
In the last 3 years, BIB traded as high as $90.91 and as low as $33.78.
BIB has outperformed the market in the last year with a return of +41.1%, while the SPY ETF gained +15.6%. However, in the most recent history, BIB shares have underperformed the stock market with its stock returning -6.9% in the last 3 month period and -8.2% for the last 2 week period, while SPY has returned -4.7% and -4.8%, respectively.
BIB support price is $75.56 and resistance is $79.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIB shares will trade within this expected range on the day.
